Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Editorial Note: In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors

  • The PLOS One Editors

The PLOS One Editors issue this Editorial Note to inform readers that works cited in this article [1] as References 14, 33, 54, and 60 were retracted after the article’s publication date. PLOS considers that these references are not crucial in supporting the research or conclusions reported in [1], but the following sentences in the Discussion section are no longer supported:

  • The sixth sentence of the second paragraph: In ovarian carcinoma, Li et al. identified reduced WDFY3-AS2 expression in tumor tissue compared to adjacent normal tissue.
  • The fifth and sixth sentences of the fourth paragraph: In vitro assays, demonstrated that AFAP1-AS1 knockdown resulted in reduced proliferation and invasion and increased apoptosis rates in MDA-MB-231 and BT-549 cell lines. In vivo, overexpression of AFAP1-AS1 promoted tumor growth and activated Wnt/β-catenin pathway to promote tumorigenesis and cell invasion by increasing the expression of C-myc and EMT related genes.

Reference

  1. 1. Rodrigues de Bastos D, Nagai MA. In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors. PLoS One. 2020;15(5):e0232284. pmid:32401758